University of Minnesota
Minneapolis, Minnesota, United States
Purpose
to test the hypothesis that HIV requires the human APOBEC3G protein to maintain a high mutation rate necessary for HIV survival. Inhibiting this protein may slow the mutation rate and make the virus more susceptible to immune responses.
Division
Global Health
Date
May 2009
Region Served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Minneapolis, Minnesota, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.